Ablynx, Bioverativ Buys Drive Sanofi's Hematology Reign

Jewels
Sanofi reigns supreme in rare blood disease after buying Bioverativ and Ablynx • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business